Texas Attorney General Ken Paxton has launched a bombshell lawsuit against pharmaceutical giants Johnson & Johnson and Kenvue, accusing them of knowingly marketing Tylenol to pregnant women while concealing evidence that its active ingredient could increase autism and ADHD risks in children.
The lawsuit, filed Tuesday, alleges the companies violated Texas consumer protection laws by promoting acetaminophen-based products as safe for use during pregnancy despite internal knowledge of potential neurological risks to developing fetuses. It represents one of the most significant legal challenges yet to the widely used over-the-counter pain reliever.
“Big Pharma betrayed America by profiting off of pain and pushing pills regardless of the risks,” Paxton said in a statement announcing the action. “These corporations lied for decades, knowingly endangering millions to line their pockets.”
Silencing Science?
At the heart of the complaint is the allegation that Johnson & Johnson not only ignored scientific evidence linking prenatal acetaminophen exposure to neurodevelopmental disorders but actively worked to suppress it. According to court documents, the company “willfully ignored and attempted to silence the science” while continuing to market Tylenol as “completely safe” for expectant mothers — claims the companies vigorously dispute.
The lawsuit further alleges Johnson & Johnson violated the Texas Uniform Fraudulent Transfer Act by shifting Tylenol-related liabilities to Kenvue, a spinoff company, in what Paxton’s office characterized as an attempt to “shield their assets against lawsuits arising from the harmful impact Tylenol had on children.”
But this isn’t just about corporate restructuring. For millions of American parents whose children have autism or ADHD, the case raises profound questions about whether a medicine cabinet staple might have contributed to their children’s conditions.
Corporate Denial
Johnson & Johnson and Kenvue have pushed back forcefully against the allegations. Both companies maintain there is no established scientific consensus linking acetaminophen use during pregnancy to autism or ADHD, with representatives denying any causal relationship between the medication and the neurodevelopmental conditions.
The legal battle comes as Tylenol and its generic equivalents remain among the most commonly used pain relievers by pregnant women in the United States, often recommended by obstetricians as the safest option for fever and pain during pregnancy.
For Paxton, this case represents the latest salvo in what his office describes as a broader campaign against pharmaceutical companies. His office previously secured a $700 million settlement with Johnson & Johnson over allegations related to talc in baby powder and has taken legal action against Pfizer regarding COVID-19 vaccine efficacy claims and Eli Lilly for alleged bribery of healthcare providers.
Legal and Medical Implications
The lawsuit could have far-reaching consequences beyond Texas. If successful, it might trigger similar actions in other states and potentially reshape guidance for pregnant women nationwide.
Medical experts not involved in the litigation caution that the scientific picture remains complex. While some studies have suggested correlations between acetaminophen use during pregnancy and slight increases in neurodevelopmental disorders, establishing causation has proven difficult, with many researchers pointing to confounding factors that could explain the statistical relationships.
“By holding Big Pharma accountable for poisoning our people, we will help Make America Healthy Again,” Paxton asserted, employing language reminiscent of former President Trump’s campaign rhetoric.
The case now enters what will likely be years of complex litigation, leaving millions of parents and pregnant women caught in an unsettling limbo between corporate denials, evolving science, and the jarring possibility that one of medicine’s most trusted remedies may carry risks few suspected.
